#878 Elevating Surgical Standards: Analyzing Morbidity and Mortality in Radical Cystectomy across Volume-Based Centers

#914 Bladder Cancer Staging with Pre-Cystoscopic mpMRI: A Multicentre Evaluation of the Vesical Imaging Reporting and Data System and Diffusion Kurtosis Imaging

#935 Initial analysis of urinary protein patterns in patients with bladder cancer

#991 Clinical experience of the orthotopic W-pouch neobladder for urinary diversion post-radical cystectomy in Indonesia: a multicenter study

#1105 Primary Malignant Melanoma of the Bladder Initially Diagnosed as Urothelial Carcinoma: A Case Report

#859 SIX1 Promotes Bladder Cancer Stemness by Repressing DHRS2-Mediated lysosomal degradation of CD44

#900 Metabolic regulation of metastasis and chemotherapy resistance of bladder cancer by HDAC2-catalyzed ARHGDIB delactylation

#933 KAT2A-mediated MECP2 lactylation enhanced malignancy of SMARCB1-deficient bladder cancer via enhancing transcription of ITGB8

#958 HDACs inhibitor sensitizes the efficacy of cisplatin via H3K18la mediated transcriptional upregulation of DHRS2 in bladder cancer

#963 Oncological outcomes of partial cystectomy versus radical cystectomy in patients with T2N0M0 bladder cancer: A retrospective study based on the SEER database

IL-22/IL22R1 promotes the progression of bladder transitional cell carcinoma by downregulating EGR1, which is achieved by YBX1 binding to its mRNA

#1016 The Potential of Preoperative LIPI as a Survival Predictor in Bladder Cancer Patients

#1108 A 10-year single center experience review of partial cystectomy from 2014 to 2024